期刊文献+

可溶性MICA在胆管癌患者外周血中表达及其临床意义

Expression of Serum Soluble MICA Protein in Patients with Cholangiocarcinoma and Its Significance
原文传递
导出
摘要 目的:探讨可溶性MICA(sMICA)在胆管癌患者外周血中的表达及其临床意义。方法:应用酶联免疫吸附试验法(ELISA)检测42例胆管癌患者的外周血sMICA的表达水平,分析其与临床病理特征的关系。结果:胆管癌患者血清sMICA水平显著高于正常对照组(P<0.01);胆管癌患者血清中sMICA的表达水平与血清中CA19-9水平、肿瘤浸润及淋巴结转移等临床病理特征密切相关(P<0.05);手术后胆管癌患者血清中sMICA水平明显下降。结论:胆管癌患者血清中sMICA水平明显增高,血清sMICA可作为胆管癌诊断的一种重要的指标。 Objective: To investigate the expression of serum soluble MICA protein in peripheral blood in the patients with cholangiocarcinoma and its clinical significance.Methods: Samples of 42 cholangiocarcinoma patients and 40 healthy persons were col-lected to detect Serum levels of sMICA by MICA-specific enzyme-linked immunosorbent assay.The association of serum sMICA levels wth clinical features were statistically analyzed.Results: The serum levels of sMICA was found to be significantly elevated in the pa-tients with cholangiocarcinoma compared with heathy subjects(P0.01).The levels of sMICA correlated significantly with CA19-9 level,tumor infltration and lymph node metastasis(all P0.05).The successful tumor resection significantly decreased serum levels of soluble MICA.Conclusion: Serum MICA levels of patients with cholangiocarcinoma are significantly increased,it is one of the important param-eters for clinical evaluation in patients with cholangiocarcinoma.
出处 《现代生物医学进展》 CAS 2011年第14期2699-2701,共3页 Progress in Modern Biomedicine
关键词 胆管癌 可溶性MICA 临床病理 Cholangiocarcinoma Soluble MICA Clinical Pathology
  • 相关文献

参考文献18

  • 1Gonza lez S, Groh V, Spies T. Immunobiology of Human NKG2D and Its Ligands[J]. Curr Top Microbiol Immunol, 2006,298:121-138.
  • 2Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases[J]. Int J Cancer, 2006,118(3):684-687.
  • 3Stasmy P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer,and in the immune response to transplants[J]. Hum Immunol, 2006,67(3): 141-144.
  • 4Vetter CS, Groh V, thor Straten P, et al. Expression of stress-induced MHC class I related chain molecules on human melanoma [J]. J. Invest. Dermatol, 2002, 118:600-605.
  • 5Jinushi M, Takehara T, Tatsumi T, et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid[J]. Int. J. Cancer, 2003,104:354-361.
  • 6Groh V, Wu J, Yee C, et al. Turnout-derived soluble MIC ligands impair expression of NKG2D and T-cell activation[J]. Nature, 2002,419: 734-738.
  • 7Watson NF. Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients[J]. Int J Cancer, 2006,18(6): 1445-1452.
  • 8Madjd Z, Spendlove I, Moss R, et al. Upregulation of MICA on high-grade invasive operable breast carcinoma [J]. Cancer Immun, 2007,7(6): 17-19.
  • 9Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer [J]. Blood Cells Mol Dis, 2005,34(3):206-213.
  • 10Fuertes MB, Girart MV, Molinero LL, et al. Intraceilular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated eytotoxicity[J]. J Immunol, 2008,180(7): 4606-4014.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部